Medpace Holdings Inc (NASDAQ:MEDP) shares are falling in Monday’s after-hours session after the company reported mixed financial results and adjusted its forward guidance. Q2 Revenue: $528.1 million, versus estimates of $528.44 million Q2 EPS: $2.75, versus estimates of $2.54 Total revenue was up 14.6% on a year-over-year basis. Medpace said its backlog increased 13.7% year-over-year to $2.925 billion. The company generated $116.4 ...